Ding H, Ding Z, Liu S, Mao X, Lu X
World J Gastroenterol. 2025; 31(8):101585.
PMID: 40062325
PMC: 11886508.
DOI: 10.3748/wjg.v31.i8.101585.
Liu B, Yasunaga J, Liang Y, Zhou R, Yang S, Yuan X
Proc Natl Acad Sci U S A. 2025; 122(8):e2416412122.
PMID: 39982744
PMC: 11874535.
DOI: 10.1073/pnas.2416412122.
Bannoura S, Khan H, Uddin M, Mohammad R, Pasche B, Azmi A
Expert Opin Drug Discov. 2024; 19(8):949-959.
PMID: 38884380
PMC: 11380440.
DOI: 10.1080/17460441.2024.2368242.
Tatrai E, Randelovic I, Surguta S, Tovari J
Cancers (Basel). 2024; 16(10).
PMID: 38791951
PMC: 11120288.
DOI: 10.3390/cancers16101872.
Niu J, Hu J, Wang Z
Toxicol Res (Camb). 2024; 13(2):tfae033.
PMID: 38525246
PMC: 10958765.
DOI: 10.1093/toxres/tfae033.
S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer.
Srivastava K, Lines K, Jach D, Crnogorac-Jurcevic T
Oncogene. 2023; 42(46):3422-3434.
PMID: 37794133
PMC: 10638088.
DOI: 10.1038/s41388-023-02851-y.
Twist family BHLH transcription factor 1 is required for the maintenance of leukemia stem cell in MLL-AF9 acute myeloid leukemia.
Wang N, Yin J, You N, Zhu W, Guo N, Liu X
Haematologica. 2023; 109(1):84-97.
PMID: 37767575
PMC: 10772510.
DOI: 10.3324/haematol.2023.282748.
VAV3 regulates glioblastoma cell proliferation, migration, invasion and cancer stem‑like cell self‑renewal.
Miao R, Huang D, Zhao K, Li Y, Zhang X, Cheng Y
Mol Med Rep. 2023; 27(4).
PMID: 36960857
PMC: 10073803.
DOI: 10.3892/mmr.2023.12981.
RHOA Therapeutic Targeting in Hematological Cancers.
Santos J, Profitos-Peleja N, Sanchez-Vinces S, Roue G
Cells. 2023; 12(3).
PMID: 36766776
PMC: 9914237.
DOI: 10.3390/cells12030433.
Eradication Can Reverse Rho GTPase Expression in Gastric Carcinogenesis.
Kim J, Kim S, Natsagdorj E, Chung H, Cho S
Gut Liver. 2023; 17(5):741-752.
PMID: 36718103
PMC: 10502497.
DOI: 10.5009/gnl220301.
Relationship between the expression of ARHGAP25 and RhoA in non-small cell lung cancer and vasculogenic mimicry.
Shi F, Wu J, Jia Q, Li K, Li W, Shi Y
BMC Pulm Med. 2022; 22(1):377.
PMID: 36207695
PMC: 9547444.
DOI: 10.1186/s12890-022-02179-5.
Nectin-4 promotes osteosarcoma progression and metastasis through activating PI3K/AKT/NF-κB signaling by down-regulation of miR-520c-3p.
Liu Y, Li G, Zhang Y, Li L, Zhang Y, Huang X
Cancer Cell Int. 2022; 22(1):252.
PMID: 35953862
PMC: 9367085.
DOI: 10.1186/s12935-022-02669-w.
Therapeutic Targeting the Allosteric Cysteinome of RAS and Kinase Families.
Li L, Meyer C, Zhou Z, Elmezayen A, Westover K
J Mol Biol. 2022; 434(17):167626.
PMID: 35595166
PMC: 9590303.
DOI: 10.1016/j.jmb.2022.167626.
Matrix metalloproteinase‑1 expression is regulated by HIF‑1‑dependent and epigenetic mechanisms and serves a tumor‑suppressive role in gastric cancer progression.
Ito K, Kitajima Y, Kai K, Matsufuji S, Yamada K, Egawa N
Int J Oncol. 2021; 59(6).
PMID: 34738626
PMC: 8577796.
DOI: 10.3892/ijo.2021.5282.
Post-translational modifications of tubulin: their role in cancers and the regulation of signaling molecules.
Wattanathamsan O, Pongrakhananon V
Cancer Gene Ther. 2021; 30(4):521-528.
PMID: 34671113
DOI: 10.1038/s41417-021-00396-4.
Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis.
Datta A, Deng S, Gopal V, Yap K, Halim C, Lye M
Cancers (Basel). 2021; 13(8).
PMID: 33919917
PMC: 8070945.
DOI: 10.3390/cancers13081882.
ARHGEF10L Promotes Cervical Tumorigenesis via RhoA-Mediated Signaling.
Tang J, Fang K, Li C, Chang X
Evid Based Complement Alternat Med. 2021; 2021:6683264.
PMID: 33833821
PMC: 8012150.
DOI: 10.1155/2021/6683264.
A genome-scale CRISPR Cas9 dropout screen identifies synthetically lethal targets in SRC-3 inhibited cancer cells.
Gilad Y, Eliaz Y, Yu Y, Dean A, Han S, Qin L
Commun Biol. 2021; 4(1):399.
PMID: 33767353
PMC: 7994904.
DOI: 10.1038/s42003-021-01929-1.
Critical role of lipid membranes in polarization and migration of cells: a biophysical view.
Sackmann E, Tanaka M
Biophys Rev. 2021; 13(1):123-138.
PMID: 33747247
PMC: 7930189.
DOI: 10.1007/s12551-021-00781-1.
Transcriptional Biomarkers in Oral Cancer: An Integrative Analysis and the Cancer Genome Atlas Validation.
Patel K, Vora H, Patel P
Asian Pac J Cancer Prev. 2021; 22(2):371-380.
PMID: 33639650
PMC: 8190349.
DOI: 10.31557/APJCP.2021.22.2.371.